Articles
New anticancer medicines approved by the EMA in 2024
Published:
2025-06-30
https://doi.org/10.71116/ksgqxh79
Authors
View
Keywords
License
Copyright (c) 2025 Miklós Bege, Borbás Anikó (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
How To Cite
Selected Style:
APA
1.
Bege M, Borbás A. New anticancer medicines approved by the EMA in 2024. DRem [Internet]. 2025 Jun. 30 [cited 2025 Dec. 5];1(2). Available from: https://ojs.lib.unideb.hu/de-remediis/article/view/15739
Received 2025-05-27
Accepted 2025-06-13
Published 2025-06-30
Accepted 2025-06-13
Published 2025-06-30
Abstract
Tumorous diseases are among the leading causes of death in the developed world, therefore there is a constant need for new antineoplastic medicines. In 2024, the EMA approved 28 anticancer drugs, of which 13 contains new active substances. In this review, we briefly summarize the mechanism of action and use of the new drugs approved by the EMA.
